Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-10-17
1993-06-22
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514220, 540555, 540560, A61K 3155, C07D49522
Patent
active
052216713
ABSTRACT:
A triazolo-1,4-di-azepine compound of the below given formulas and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases. ##STR1## in which R1 and R2 are hydrogen or an alkyl, R3 is hydrogen or a halogen, R4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.
REFERENCES:
patent: 4049559 (1991-09-01), Braquet et al.
patent: 4959361 (1990-09-01), Walser
patent: 4960770 (1990-10-01), Moriwaki et al.
patent: 4968794 (1990-11-01), Weber et al.
patent: 5049560 (1991-09-01), Esanu et al.
Okano et al, Chemical Abstract vol. 113, No. 212028s, (1990).
Tsunoda et al., Chemical Abstract vol. 114, No. 55582u (1990).
Abe Shinya
Asano Osamu
Clark Richard S. J.
Harada Koukichi
Katayama Kouichi
Datlow Philip I.
Eisai Co. Ltd.
Shah Mukund J.
LandOfFree
Triazolo-1,4-diazepine derivatives and their use in pharmaceutic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolo-1,4-diazepine derivatives and their use in pharmaceutic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolo-1,4-diazepine derivatives and their use in pharmaceutic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1441142